Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$864K Hold
4,000
0.46% 37
2026
Q1
$733K Sell
4,000
-2,000
-33% -$369K 0.44% 40
2025
Q4
$1.06M Buy
6,000
+4,000
+200% +$653K 0.49% 33
2025
Q3
$280K Buy
+2,000
New +$270K 0.11% 59

Other funds holding BIIB

David M. Knott Jr's BIIB Position: Q2 2026 in Review

David M. Knott Jr held its Biogen (BIIB) position steady in Q2 2026 at 4,000 shares worth $864K. The position accounts for 0.46% of the portfolio, ranked #37.

David M. Knott Jr first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.06M in Q4 2025. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • David M. Knott Jr held 4,000 shares of Biogen worth $864K as of Q2 2026.
  • David M. Knott Jr left its Biogen share count unchanged in Q2 2026.
  • Biogen made up 0.46% of David M. Knott Jr's portfolio in Q2 2026, its #37 holding.
  • David M. Knott Jr first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • David M. Knott Jr's Biogen position peaked at $1.06M in Q4 2025.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.